Susan Chi
Clinical Director of Pediatric Neuro-Oncology · Mass General Brigham
Credentials: · · ·
History
- Present
Pediatric Neuro-Oncology · Mass General Brigham
- Present
- 1998–1999
New York University Medical Center
- 1994–1997
Yale New Haven Children's Hospital
Research
Mechanisms and therapeutic implications of hypermutation in gliomas
Nature · 2020 · 538 citations
Journal of Clinical Oncology · 2009 · First of 20 authors · Corresponding · 337 citations
Journal of Clinical Oncology · 2011 · 262 citations
- MK
38 papers
- LG
24 papers
19 papers
- KM
18 papers
18 papers
18 papers · 7 as a fellow
- PM
18 papers
17 papers
Clinical trials
- 2026–2032
- 2023–2029
Tazemetostat+Nivo/Ipi in INI1-Neg/SMARCA4-Def Tumors
Principal investigator · Active not recruiting · Phase 1, Phase 2
Susan Chi, MD
- 2025–2035
Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
Study chair · Recruiting · Early phase 1
Nationwide Children's Hospital
- 2021–2036
A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion
Study chair · Recruiting · Early phase 1
Nationwide Children's Hospital